Inspire Medical Systems, Inc. (INSP) earnings date, results and what the price requires
NYSE · SEC CIK 0001609550 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | $200.6M | $314,000 | $0.01 | Filing |
| Mar 31, 2026 | May 4, 2026 | $204.6M | $-11.3M | $-0.39 | Filing |
| Dec 31, 2025 | Jan 12, 2026 | $269.1M | $136.1M | $4.57 | Filing |
| Sep 30, 2025 | Nov 3, 2025 | $224.5M | $9.9M | $0.34 | Filing |
| Jun 30, 2025 | Aug 4, 2025 | $217.1M | $-3.6M | $-0.12 | Filing |
| Mar 31, 2025 | May 5, 2025 | $201.3M | $3.0M | $0.10 | Filing |
| Dec 31, 2024 | Jan 13, 2025 | $239.7M | $35.2M | $1.17 | Filing |
| Sep 30, 2024 | Nov 4, 2024 | $203.2M | $18.5M | $0.60 | Filing |
What would Inspire Medical Systems, Inc. have to report for its valuation to change?
At $70.12, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 5.8% a year, to $5.99. On that path the next quarter needs diluted EPS near $0.36, against $0.34 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 5.8% | 5.8% |
| EPS needed in final year | $5.99 | $5.99 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. INSP goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.